Net profit of Sandu Pharmaceuticals rose 118.52% to Rs 0.59 crore in the quarter ended March 2024 as against Rs 0.27 crore during the previous quarter ended March 2023. Sales rose 2.23% to Rs 15.60 crore in the quarter ended March 2024 as against Rs 15.26 crore during the previous quarter ended March 2023.For the full year,net profit declined 3.95% to Rs 1.46 crore in the year ended March 2024 as against Rs 1.52 crore during the previous year ended March 2023. Sales rose 2.95% to Rs 67.28 crore in the year ended March 2024 as against Rs 65.35 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales15.6015.26 2 67.2865.35 3 OPM %3.853.21 -3.423.79 - PBDT0.910.51 78 2.662.73 -3 PBT0.720.38 89 2.072.22 -7 NP0.590.27 119 1.461.52 -4 Powered by Capital Market - Live News

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 June 2024.Powered by Capital Market - Live News

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 March 2024. The meeting would commence at 6.00 PM.Powered by Capital Market - Live News

Net profit of Sandu Pharmaceuticals declined 56.25% to Rs 0.21 crore in the quarter ended December 2023 as against Rs 0.48 crore during the previous quarter ended December 2022. Sales rose 1.99% to Rs 17.43 crore in the quarter ended December 2023 as against Rs 17.09 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales17.4317.09 2 OPM %2.934.80 - PBDT0.520.83 -37 PBT0.380.70 -46 NP0.210.48 -56 Powered by Capital Market - Live News